Food and Drug Administration

Anti-Infective Drugs Advisory Committee

February 20, 2002

Approaches to the development of antimicrobial agents for the treatment of resistant pathogens

Issues for Discussion - Questions (New 03/13/02)  ppt   htm


Antibiotic resistance: An Update, Janice Soreth, MD, Division of Anti-Infective Drug Products   ppt   htm

Developing Drugs for Resistant Pathogens: Problems and Possibilities, David Ross, MD, PhD   ppt   htm

Development of Antibacterial Drugs for Infections with Resistant Pathogens, David Shlaes, MD, Antimicrobial Working Group of the Pharmaceutical Research and Manufacturers of America (PhRMA)   ppt   htm

Resistance in NYC Seven Hospital Consortium, Louis Rice, MD on behalf of the Infectious Diseases Society of America (IDSA)   ppt   htm

Development of Drugs for Resistant Pathogens, Francis P Tally, MD, Cubist Pharmaceuticals, Inc.   ppt   htm

Open Public Hearing

Antibiotic Development Strategies to Understand and Label Microbial Endpoints such as Slow Killing, Resistance and Failure, AUIC Dosing and Success via Synergy, Jerome J Schentag, PharmD, University at Buffalo   ppt   htm

Prevention of Emergence of Resistance:  A Pharmacodynamic Solution, G L Drusano, MD, Albany Medical College & New York State Department of Health   ppt   htm